Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) announced its participation in key investor conferences in June and July 2022. The company will present at the Jefferies Healthcare Conference on June 9 at 9:00 a.m. ET and the Guggenheim I&I Spotlight Series focused on Treg-based therapies on July 12 at 2:45 p.m. ET. Access to presentations will be available on the company's website. Sangamo Therapeutics specializes in genomic medicines, utilizing innovative zinc finger technology to address treatment gaps for patients.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

• Jefferies Healthcare Conference
  Date: Thursday, June 9 at 9:00 a.m. Eastern Time

• Guggenheim I&I Spotlight Series – Treg-based Therapies
  Date: Tuesday, July 12 at 2:45 p.m. Eastern Time

Access links for presentations, panels and fireside chats will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601006208/en/

Investor Relations & Media Inquiries

Louise Wilkie

ir@sangamo.com

media@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

What conferences will Sangamo Therapeutics participate in?

Sangamo Therapeutics will present at the Jefferies Healthcare Conference on June 9 and the Guggenheim I&I Spotlight Series on July 12.

When is the Jefferies Healthcare Conference for Sangamo?

The Jefferies Healthcare Conference is scheduled for June 9, 2022, at 9:00 a.m. Eastern Time.

What is the date and time for the Guggenheim I&I Spotlight Series?

The Guggenheim I&I Spotlight Series will take place on July 12, 2022, at 2:45 p.m. Eastern Time.

Where can I access Sangamo Therapeutics conference presentations?

You can access the presentations on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

What is Sangamo Therapeutics focused on?

Sangamo Therapeutics is focused on developing genomic medicines using zinc finger genome engineering technology.